Idiopathic trigeminal neuralgia. Disorder of trigeminal nerve, unspecified
Conditions
Interventions
Intervention 1: Intervention group 1: Injection of 2 ml of orthokine, 4 times (once a week) each with a dose of 2 milliliters under fluoroscopic guide through foramen oval with 22 spinal needles. Int
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Confirmation of idiopathic trigeminal neuralgia, based on diagnostic criteria of the International Headache Association Trigeminal neuralgic pain, with an intensity of 40 to 100 based on the visual analog scale of 100 mm
Exclusion criteria
Exclusion criteria: Bleeding disorders Active infection Type 2 diabetes Patients with pacemaker Patients with internal drug injection devices Neoplasm Drug addiction Psychopathy Drug sensitivity Pregnancy and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ?ain intensity. Timepoint: Pain intensity at the beginning of the study (before the intervention) and 7, 14 and 21 days after the start of intervention. Method of measurement: 100-mm Visual Analogue Scale.;Analgesic consumption. Timepoint: Analgesic consumption at the beginning of the study (before the intervention) and 7, 14, and 21 days after the intervention. Method of measurement: Self-reported. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDawood Aghamohammadi
Tabriz University of Medical Sciences
Outcome results
None listed